Abstract
Combined therapy with inhaled corticosteroids (ICSs) and long-acting beta(2)-adrenoceptor agonists (LABAs) is the recommended approach for the treatment of patients with asthma that is uncontrolled on ICSs alone. Additional studies are needed to assess the safety and efficacy of combination treatment with ICSs and LABAs in patients with mild asthma. The aim of this study was to compare the efficacy and tolerability of once-daily salmeterol/fluticasone propionate combination (SFC) with once-daily fluticasone propionate (FP) over a 12-week treatment period in patients with mild persistent asthma. This was a randomized, double-blind, placebo-controlled, parallel-group, multicentre study carried out in primary care or at a hospital outpatient department and included patients 12-79 years of age with mild persistent asthma (n = 458). After a 2-week run-in period, patients were randomized to receive SFC 50 microg/100 microg (n = 149), FP 100 microg (n = 154) or placebo (n = 155) once daily in the morning for 12 weeks. The primary efficacy endpoint was patient-recorded pre-dose mean morning peak expiratory flow (PEF). Other assessments included asthma symptom scores, use of rescue medication and investigator-recorded exacerbations. Lun...Continue Reading
References
Jul 23, 1994·Lancet·A P GreeningG Shaw
Mar 14, 1998·Chest·J G Teeter, E R Bleecker
Jul 29, 1998·The Journal of Allergy and Clinical Immunology·D B PedenK W House
Aug 11, 2000·Chest·R ZuWallackS M Harding
Dec 2, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·C F LaForceK W House
Oct 24, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·William E BergerKathleen Rickard
Oct 14, 2003·Chest·Mary E PuruckerRobert J Meyer
Jul 17, 2004·American Journal of Respiratory and Critical Care Medicine·Eric D BatemanUNKNOWN GOAL Investigators Group
Oct 16, 2004·Respiratory Medicine·Anne Mette StrandUNKNOWN Danish INitiative for Asthma treatment
Mar 15, 2005·Respiratory Medicine·J A E WaltersE H Walters
Apr 13, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·Matthew MasoliRichard Beasley
Apr 13, 2005·Respiratory Medicine·Matthew MasoliRichard Beasley
Aug 19, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Sarah AldingtonRichard Beasley
Aug 22, 2006·Respiratory Research·Jan LötvallAshley Woodcock
May 18, 2007·The New England Journal of Medicine·Alberto PapiUNKNOWN BEST Study Group
Jun 22, 2007·The New England Journal of Medicine·Laura E FredenburghJeffrey M Drazen
Citations
Feb 13, 2008·Clinical Drug Investigation·Alexander ChuchalinLucy Frith
Jan 30, 2010·Clinical Therapeutics·Christian FroisGene L Colice
Nov 26, 2008·Pulmonary Pharmacology & Therapeutics·Gustavo J RodrigoJosé A Castro-Rodriguez
Jan 26, 2018·Drugs·Eckard Hamelmann, Stanley J Szefler
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Muireann Ni ChroininFrancine M Ducharme